← Leaderboards
Kim Carol Jonas
King'S College London
$1,142,843
Attributed
$1,512,694
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $619.7K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,512,694 · 2
By mechanism
P01$772,992 · 1
R01$739,702 · 1
Top collaborators
- John S Davis2 shared
Others in their field
Other Rising Stars on “Glycoproteins”
- Robert W Cross · University Of Texas Med Br Galveston$4,640,498
- Kai Xu · Ohio State University$4,531,041
- Courtney Cohen · Albert Einstein College Of Medicine$3,541,248
- Torben Schiffner · Vanderbilt University$3,383,634
- Goran Bajic · Icahn School Of Medicine At Mount Sinai$3,116,277
- Choi-Fong Cho · Brigham And Women'S Hospital$2,666,597
Research focus
GlycoproteinsGlycosylationFollicle Stimulating HormoneAgingGenerationsFolliculogenesisAdaptor Signaling ProteinEndosomesBiological MarkersCell LineFollicle Stimulating Hormone ReceptorAssisted Reproductive TechnologyAge RelatedColorBindingComplexBinding ProteinsCoupledCyclic AmpDimerDissociationEncryptionCell MembraneG-Protein-Coupled Receptors
Grant awards (5)
Understanding The Role Of FSHR Oligomerization And Trafficking In Transducing Age-dependent Changes In FSH Glycoforms$352,847
R01 · FY2025 · HD · contact PI
Project 3: Understanding the Role of FSHR Oligomerization and Trafficking in Transducing Age-dependent Changes in FSH Glycoforms$216,806
P01 · FY2025 · AG · contact PI
Understanding The Role Of FSHR Oligomerization And Trafficking In Transducing Age-dependent Changes In FSH Glycoforms$386,855
R01 · FY2024 · HD · contact PI
Project 3: Understanding the Role of FSHR Oligomerization and Trafficking in Transducing Age-dependent Changes in FSH Glycoforms$232,797
P01 · FY2024 · AG · contact PI
Project 3: Understanding the Role of FSHR Oligomerization and Trafficking in Transducing Age-dependent Changes in FSH Glycoforms$323,389
P01 · FY2023 · AG · contact PI